Baxter International (BAX -0.5%) says the results from two large, international multicenter...

|About: Baxter International Inc (BAX)|By:, SA News Editor

Baxter International (BAX -0.5%) says the results from two large, international multicenter trials it conducted show that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids. The combined results were presented at the 49th Annual European Renal Association - European Dialysis and Transplant Association congress in Paris.